SCHEMBL4509367

SCHEMBL4509367

Cc1cc(C)nc(NC(=O)N2CCOC(COc3ccccc3Cl)C2)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.51
MAPT P10636 2/20 0.51
KMT2A Q03164 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
KDM4E B2RXH2 1/20 0.51
PKM P14618 1/20 0.51
TRPV1 Q8NER1 1/20 0.43
PHGDH O43175 3/20 0.42
PDK1 Q15118 1/20 0.42
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
GRM5 P41594 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
DRD4 P21917 2/20 0.41
EPHA2 P29317 6/20 0.40
KDR P35968 6/20 0.40
EPHB4 P54760 3/20 0.40
ABL1 P00519 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4516917 0.91 EPHA2 (0.44) MEN1MAPTKMT2ASMN1; SMN2KDM4E
SCHEMBL4506372 0.90 TRPV1 (0.43) MEN1MAPTKMT2ASMN1; SMN2KDM4E
SCHEMBL4510657 0.89 PDK1 (0.46) MAPTKMT2APDK1LMNAGRM5
Trifluoroacetic Acid SCHEMBL4518310 0.88 PHGDH (0.40) MEN1MAPTKMT2ASMN1; SMN2KDM4E
SCHEMBL4496536 0.87 RBP4 (0.46) TRPV1PHGDHPDK1
Trifluoroacetic Acid SCHEMBL4504667 0.87 EPHA2 (0.41) MEN1MAPTKMT2ASMN1; SMN2KDM4E
Trifluoroacetic Acid SCHEMBL4498992 0.85 PHGDH (0.40) MEN1KMT2AKDM4EPHGDHALDH1A1
Trifluoroacetic Acid SCHEMBL4495237 0.85 TRPV1 (0.40) TRPV1PHGDHPDK1GRM5DRD4
Trifluoroacetic Acid SCHEMBL4516133 0.85 EPHA2 (0.41) MEN1MAPTKMT2ASMN1; SMN2KDM4E
SCHEMBL4509117 0.85 MEN1 (0.53) MEN1MAPTKMT2ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325956-A1 Aromatic amine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325956-A1 Aromatic amine derivative and use thereof SCD, SCD5, SMS MEN1 4180/4885MAPT 4022/4885KMT2A 1109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.